1. Document de presse | 2021.07.21

   SARS-CoV-2 damages ciliated cells and inhibits mucociliary clearance in the airways

   COVID-19 is a viral disease with respiratory symptoms that can induce fatal pneumonia. Understanding how SARS-CoV-2 spreads in the respiratory tract can help scientists identify the parameters controlling the severity of infection. Scientists from the Institut Pasteur, the CNRS and Inserm found that SARS-CoV-2 multiplies efficiently in the respiratory tract, and that it primarily targets ciliated...

2. News | 2021.09.09

   SPKM001, a promising anti-SARS-CoV-2 monoclonal antibody, is being developed by the Institut Pasteur and SpikImm

   Following encouraging initial results, which will be published shortly, the Institut Pasteur and SpikImm announce the development of the antibody SPKM001.Paris, September 9, 2021SPKM001 is a high affinity human monoclonal antibody which targets the receptor-binding site (RBD) on the Spike protein of the original SARS-CoV-2 strain and its variants.Initial preclinical results tend to show that this...

3. Document de presse | 2021.09.27

   SARS-CoV-2: different immune responses observed in nasal mucosa and blood

   The clinical manifestations of SARS-CoV-2 infection vary from one individual to the next, and much remains unknown about the mechanisms underpinning this variability. Since the nasal mucosa is one of the first entry points of the virus, scientists from the Institut Pasteur and Inserm, in collaboration with Cochin AP-HP Hospital, analyzed in parallel the immune responses in the nasal mucosa and in...

4. News | 2022.01.12

   French Prime Minister Jean Castex salutes the Institut Pasteur's expertise on emerging infectious diseases

   French Prime Minister Jean Castex, accompanied by Frédérique Vidal, Minister of Higher Education, Research and Innovation, visited the Institut Pasteur on Monday January 10, 2022, to salute the efforts of scientists in the ongoing battle against COVID-19. The visit was an opportunity to highlight the need to strengthen preparedness for future emerging diseases. It was also an auspicious moment...

5. Document de presse | 2023.03.31

   The Institut Pasteur and the University of São Paulo sign articles of association to establish the Institut Pasteur in São Paulo

   On Friday March 31st, 2023 at a ceremony in Paris, the Institut Pasteur President, Professor Stewart Cole, and the University of São Paulo (USP) Rector, Carlos Gilberto Carlotti Junior, signed articles of association for the Institut Pasteur in São Paulo, a private non-profit organization under Brazilian law. The mission of the institute, an associate member of the Pasteur Network, is to conduct...

6. Article | 2017.06.19

   Call For Projects Fiocruz - Institut Pasteur – USP

   The Oswaldo Cruz Foundation (Fiocruz), the Institut Pasteur and the University of São Paulo (USP) are launching a common call for projects. This call is also open to the members of the Pasteur Network.

7. Article | 2017.01.04

   Pasteur-Cnam-EHESP School of Public Health

   The Institut Pasteur and the Cnam (National Conservatory of Arts and Crafts), in partnership with the EHESP (French School of Public Health), have combined their complementary expertise within the Pasteur-Cnam-EHESP School of Public Health to offer an Advanced Master degree - Mastère Spécialisé in Public Health.

8. News | 2020.05.20

   Blood test: a potential new tool for controlling infections

   A new technique could provide vital information about a community’s immunity to infectious diseases including malaria and Covid-19.The diagnostic test analyses a blood sample to reveal immune markers that indicate whether – and when – a person was exposed to an infection. It was developed to track malaria infections in communities, to assist in the elimination of deadly ‘relapsing’ malaria, but...

9. News | 2024.09.18

   Whooping cough: how do we explain its resurgence in 2024 in France?

   In a study coordinated by the Institut Pasteur, scientists describe the dynamics of the whooping cough epidemic in 2024 in France, the worst in 25 years. The scientists also sequenced the genome of almost 70 bacterial isolates collected during the outbreak from January to mid-2024. These analyses allowed them to put forward several theories explaining the current resurgence in circulation of the...

10. Document de presse | 2020.05.26

    MV-SARS-CoV-2 vaccine candidate: a new partnership between Institut Pasteur, CEPI, Thémis and MSD

    Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using the measles vector, as part of a renewed partnership with CEPI and the companies Thémis and MSD.With over 100 vaccine projects in development worldwide, the development of a vaccine against SARS CoV-2 infection remains a challenge, with many scientific uncertainties ahead. The...

Pages